- Home
- / Adial Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Adial Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1
2024-10-29
Market Capitalization
$6.7 M
2024-10-29
CreditSafe Score
?
Score changed on Jul 18, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| General and administrative expense | 6.6M | 4.3M | 5.1M | 9.3M | 9.1M | 5.6M | 5.1M | |
| Operating expense total | 7.0M | 8.2M | 10.9M | 13.3M | 8.3M | |||
| EBIT | (7.0M) | (8.2M) | (10.9M) | (19.3M) | (13.3M) | (6.9M) | (8.3M) | |
| Investment income | (552.2K) | |||||||
| Interest income | 7.4K | 95.2K | 32.5K | 6.5K | 63.2K | 69.8K | 178.7K | |
| Pre tax profit | (11.6M) | (8.6M) | (10.9M) | (19.5M) | (12.7M) | (7.0M) | (13.2M) | (8.0M) |
| Income tax expense | (697.9K) | (225.9K) | (446.4K) | (94.1K) | (502.0) | |||
| Net Income | (11.6M) | (8.6M) | (10.9M) | (19.4M) | (12.7M) | (5.1M) | (13.2M) | |
| EPS | (0.5) | (3.0) | (2.7) | (11.9) |